The versatility of the quinazoline scaffold enables the incorporation of diverse functional groups, enhancing its potential to modulate key processes involved in the pathogenesis of AD, such as cholinergic deficit, β-amyloid aggregation, tau protein hyperphosphorylation, and oxidative stress. The gene discussed is MAPT; the disease is Alzheimer disease.